Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€133.72

€133.72

0.450%
0.6
0.450%
€193.80
 
29.08.25 / Tradegate WKN: A1KBYX / Symbol: ZTS / Name: Zoetis / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Zoetis Inc. A Stock

Zoetis Inc. A gained 0.450% compared to yesterday.
Zoetis Inc. A is currently one of the favorites of our community with 15 Buy predictions and no Sell predictions.
With a target price of 193 € there is a positive potential of 44.33% for Zoetis Inc. A compared to the current price of 133.72 €.
So far the community has only identified positive things for Zoetis Inc. A stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Zoetis Inc. A in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Zoetis Inc. A vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Zoetis Inc. A 0.450% 0.105% 4.599% -19.446% -14.698% -14.183% -0.343%
Johnson & Johnson 0.880% -0.968% 4.918% 0.973% 8.916% -5.655% 17.847%
Elanco Animal Health Inc. -1.140% 2.697% 30.837% 12.136% 35.868% 4.252% -35.604%
Pfizer Inc. 0.400% -4.146% 3.676% -19.363% -16.614% -52.989% -29.661%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-12-04

When examining the financials of Zoetis (NYSE: ZTS), a leading company in the pharmaceutical industry, a preliminary review reveals a robust picture with consistent growth in total assets over the last three years. This growth is coupled with a stable increase in shareholder equity, indicating prudent financial management and a strong balance sheet foundation. A deeper dive into the detailed numbers should provide further insights into the organization's financial health, as well as potential areas of caution.

Growing Top Line: Zoetis has demonstrated a steady increase in total revenues, with the trailing twelve-month (TTM) revenue at approximately $8.37 billion. The year-over-year quarterly revenue growth of 7.4% signals a solid capacity for expanding their market presence and sales effectiveness.

EBITDA and Operating Margins: The EBITDA and operating margins are notable strengths, with a TTM EBITDA of around $3.47 billion and an operating margin of 37.1%. These numbers suggest efficient operational management and profitability.

Comments

Prediction Buy
Perf. (%) 4.94%
Target price 184.320
Change
Ends at 11.08.26

Zoetis Inc. (NYSE: ZTS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $215.00 price target on the stock, up previously from $210.00.
Ratings data for ZTS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -9.18%
Target price 187.068
Change
Ends at 12.05.26

Zoetis Inc. (NYSE: ZTS) had its price target raised by analysts at Piper Sandler from $205.00 to $210.00. They now have an "overweight" rating on the stock.
Ratings data for ZTS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 0.75%
Target price 144.903
Change
Ends at 14.04.26

Zoetis Inc. (NYSE: ZTS) had its price target lowered by analysts at Stifel Nicolaus from $180.00 to $165.00. They now have a "buy" rating on the stock.
Ratings data for ZTS provided by MarketBeat
Show more

News

If You'd Invested $1,000 in Zoetis (ZTS) Stock 10 Years Ago, Here's How Much You'd Have Today: https://g.foolcdn.com/editorial/images/827351/getty-happy-smiling-person-with-cat-pet-animal.jpg
If You'd Invested $1,000 in Zoetis (ZTS) Stock 10 Years Ago, Here's How Much You'd Have Today

Ah, 10 years ago. It was 2015, and selfie sticks and hoverboards were all over. Apple debuted its Apple Watch to much fanfare, and...perhaps you invested in shares of Zoetis (NYSE: ZTS) stock? If

1 Top Dividend Growth Stock to Buy and Hold Forever: https://g.foolcdn.com/editorial/images/827433/pet-owners-walking-their-dog.jpg
1 Top Dividend Growth Stock to Buy and Hold Forever

There are many reasons to invest in dividend stocks. Companies that offer regular payouts tend to have strong underlying operations and generate consistent revenue and profits, making them excellent

2 Dividend Growth Stocks to Buy and Hold Forever: https://g.foolcdn.com/editorial/images/823424/pet-owners-walking-their-dog.jpg
2 Dividend Growth Stocks to Buy and Hold Forever

For investors focused on the long game, there is little reason to sell -- at least, so long as a company generates solid returns through consistently improving financial results, regularly increases